Raptor Pharmaceutical Corp

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$68.1M

898 transactions

Summary

Raptor Pharmaceutical Corp is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $11.2MSales: $39.4M60 insiders

Date	Insider	Type	Value
2016-10-25	Smith Julie(President and CEO)	D	$578K
2016-10-25	Polu Krishna R(Chief Medical Officer)	D	$214K
2016-10-25	STARR CHRISTOPHER M	D	$75K
2016-10-25	FRANKLIN RICHARD L	D	$75K
2016-10-25	Keltner Llew	D	$75K
2016-10-25	Polu Krishna R(Chief Medical Officer)	D	—
2016-10-25	STARR CHRISTOPHER M	D	—
2016-10-25	STARR CHRISTOPHER M	D	—
2016-10-25	FRANKLIN RICHARD L	D	—
2016-10-25	FRANKLIN RICHARD L	D	—
2016-10-25	FRANKLIN RICHARD L	D	—
2016-10-25	Keltner Llew	D	—
2016-10-25	Keltner Llew	D	—
2016-10-25	Keltner Llew	D	—
2016-10-25	Smith Julie(President and CEO)	D	—
2016-10-25	Smith Julie(President and CEO)	D	—
2016-10-25	Smith Julie(President and CEO)	D	—
2016-10-25	Anderson Raymond	D	—
2016-10-25	Anderson Raymond	D	—
2016-10-25	Anderson Raymond	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Raptor Pharmaceutical Corp — Contributions, Lobbying & Contracts | Poliscope